Biggest changeThe CODM does not review assets by segment in his resource allocation and therefore, assets by segment are not disclosed below. 30 Table of Contents The following tables set forth the Company’s consolidated statements of operations by business segment (in thousands ): Year Ended December 31, 2023 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 956,077 $ 131,537 $ – $ 1,087,614 Other revenues 1,141 – 52,789 53,930 Net operating revenues 957,218 131,537 52,789 1,141,544 Costs and Expenses: Salaries, wages and benefits 589,279 80,610 42,455 712,344 Other operating 254,559 23,529 10,095 288,183 Facility rent 33,787 2,172 5,566 41,525 Depreciation and amortization 38,172 786 3,076 42,034 Interest 324 – – 324 Total costs and expenses 916,121 107,097 61,192 1,084,410 Income (loss) before non-operating income 41,097 24,440 (8,043 ) 57,134 Non-operating income – – 16,660 16,660 Unrealized gains on marketable equity securities – – 14,944 14,944 Income before income taxes $ 41,097 $ 24,440 $ 23,201 $ 88,738 Year Ended December 31, 2022 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 900,231 $ 128,854 $ – $ 1,029,085 Other revenues 136 – 45,060 45,196 Government stimulus income 11,457 – – 11,457 Net operating revenues and grant income 911,824 128,854 45,060 1,085,738 Costs and Expenses: Salaries, wages and benefits 580,707 77,688 27,774 686,169 Other operating 251,355 26,319 11,698 289,372 Facility rent 32,956 2,327 5,694 40,977 Depreciation and amortization 36,522 691 3,276 40,489 Interest 563 – – 563 Recovery of assets – – (3,728 ) (3,728 ) Total costs and expenses 902,103 107,025 44,714 1,053,842 Income before non-operating income 9,721 21,829 346 31,896 Non-operating income – – 11,141 11,141 Unrealized losses on marketable equity securities – – (15,806 ) (15,806 ) Income (loss) before income taxes $ 9,721 $ 21,829 $ (4,319 ) $ 27,231 31 Table of Contents Year Ended December 31, 2021 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 868,687 $ 96,855 $ – $ 965,542 Other revenues 386 – 45,014 45,400 Government stimulus income 63,360 – – 63,360 Net operating revenues and grant income 932,433 96,855 45,014 1,074,302 Costs and Expenses: Salaries, wages and benefits 557,604 59,226 49,233 666,063 Other operating 238,354 16,053 12,347 266,754 Facility rent 32,819 2,064 5,935 40,818 Depreciation and amortization 36,890 443 3,339 40,672 Interest 845 – – 845 Impairment of assets 4,497 – 3,728 8,225 Total costs and expenses 871,009 77,786 74,582 1,023,377 Income (loss) before non-operating income 61,424 19,069 (29,568 ) 50,925 Non-operating income – – 17,774 17,774 Gain on acquisition of equity method investment – – 95,202 95,202 Unrealized losses on marketable equity securities – – (13,863 ) (13,863 ) Income before income taxes $ 61,424 $ 19,069 $ 69,545 $ 150,038 Non-GAAP Financial Presentation The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods.
Biggest changeThe CODM does not review assets by segment in his resource allocation and therefore, assets by segment are not disclosed below. 31 Table of Contents The following tables set forth the Company’s consolidated statements of operations by business segment (in thousands ): Year Ended December 31, 2024 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 1,111,300 $ 140,459 $ – $ 1,251,759 Other revenues 1,315 – 44,863 46,178 Government grant income – – 9,445 9,445 Net operating revenues and grant income 1,112,615 140,459 54,308 1,307,382 Costs and Expenses: Salaries, wages and benefits 668,029 85,712 57,189 810,930 Other operating 280,867 25,927 14,596 321,390 Facility rent 33,787 2,295 7,100 43,182 Depreciation and amortization 37,988 737 3,260 41,985 Interest 4,135 – – 4,135 Total costs and expenses 1,024,806 114,671 82,145 1,221,622 Income (loss) before non-operating income 87,809 25,788 (27,837 ) 85,760 Non-operating income – – 19,690 19,690 Unrealized gains on marketable equity securities – – 30,958 30,958 Income before income taxes $ 87,809 $ 25,788 $ 22,811 $ 136,408 Year Ended December 31, 2023 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 956,077 $ 131,537 $ – $ 1,087,614 Other revenues 1,141 – 52,789 53,930 Net operating revenues 957,218 131,537 52,789 1,141,544 Costs and Expenses: Salaries, wages and benefits 589,279 80,610 42,455 712,344 Other operating 254,559 23,529 10,095 288,183 Facility rent 32,542 2,172 6,811 41,525 Depreciation and amortization 38,172 786 3,076 42,034 Interest 324 – – 324 Total costs and expenses 914,876 107,097 62,437 1,084,410 Income (loss) before non-operating income 42,342 24,440 (9,648 ) 57,134 Non-operating income – – 16,660 16,660 Unrealized gains on marketable equity securities – – 14,944 14,944 Income before income taxes $ 42,342 $ 24,440 $ 21,956 $ 88,738 32 Table of Contents Year Ended December 31, 2022 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 900,231 $ 128,854 $ – $ 1,029,085 Other revenues 136 – 45,060 45,196 Government grant income 11,457 – – 11,457 Net operating revenues and grant income 911,824 128,854 45,060 1,085,738 Costs and Expenses: Salaries, wages and benefits 580,707 77,688 27,774 686,169 Other operating 251,355 26,319 11,698 289,372 Facility rent 32,526 2,327 6,124 40,977 Depreciation and amortization 36,522 691 3,276 40,489 Interest 563 – – 563 Recovery of assets – – (3,728 ) (3,728 ) Total costs and expenses 901,673 107,025 45,144 1,053,842 Income before non-operating income 10,151 21,829 (84 ) 31,896 Non-operating income – – 11,141 11,141 Unrealized losses on marketable equity securities – – (15,806 ) (15,806 ) Income (loss) before income taxes $ 10,151 $ 21,829 $ (4,749 ) $ 27,231 Non-GAAP Financial Presentation The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods.
Credit losses are recorded as bad debt expense, which is included as a component of other operating expenses consolidated statements of operations Revenue Recognition – Third Party Payors Medicare and Medicaid program revenues, as well as certain Managed Care program revenues, are subject to audit and retroactive adjustment by government representatives or their agents.
Credit losses are recorded as bad debt expense, which is included as a component of other operating expenses in the consolidated statements of operations Revenue Recognition – Third Party Payors Medicare and Medicaid program revenues, as well as certain Managed Care program revenues, are subject to audit and retroactive adjustment by government representatives or their agents.
For the years ended December 31, 2023 and 2022, respectively, we recorded $0 and $11,457,000 in government stimulus income related to funds received from the CARES Act Provider Relief Fund. Total costs and expenses Total costs and expenses for 2023 increased $30,568,000, or 2.9%, to $1,084,410,000 from $1,053,842,000 in 2022.
For the years ended December 31, 2023 and 2022, respectively, we recorded $0 and $11,457,000 in government grant income related to funds received from the CARES Act Provider Relief Fund. Total costs and expenses Total costs and expenses for 2023 increased $30,568,000, or 2.9%, to $1,084,410,000 from $1,053,842,000 in 2022.
Our primary uses of cash include salaries, wages and other operating costs of our healthcare operations, the cost of additions to and acquisitions of real property, facility rent expenses, and dividend distributions. These sources and uses of cash are reflected in our interim condensed consolidated statements of cash flows and are discussed in further detail below.
Our primary uses of cash include salaries, wages and other operating costs of our healthcare operations, the cost of additions to and acquisitions of real property, facility rent expenses, and dividend distributions. These sources and uses of cash are reflected in our consolidated statements of cash flows and are discussed in further detail below.
Guarantees At December 31, 2023, we have no agreements to guarantee the debt obligations of other parties. We have no outstanding letters of credit. We may or may not in the future elect to use financial derivative instruments to hedge interest rate exposure in the future. At December 31, 2023, we did not participate in any such financial instruments.
Guarantees At December 31, 2024, we have no agreements to guarantee the debt obligations of other parties. We have no outstanding letters of credit. We may or may not in the future elect to use financial derivative instruments to hedge interest rate exposure in the future. At December 31, 2024, we did not participate in any such financial instruments.
New operations, which include one skilled nursing facility acquired May 1, 2023, three assisted living facilities that we began operating on July 1, 2023, two behavioral health hospitals, two hospice agencies and two homecare agencies, have attributed to an increase of $25,821,000 in net patient revenues for the year ended December 31, 2023 compared to the same period last year.
New operations, which include one skilled nursing facility acquired May 1, 2023, three assisted living facilities that we began operating on July 1, 2023, two behavioral health hospitals, two hospice agencies and two homecare agencies, have attributed to an increase of $25,821,000 in net patient revenues for the year ended December 31, 2023 compared to the prior year.
New operations, which include one skilled nursing facility acquired May 1, 2023, three assisted living facilities that we began operating on July 1, 2023, two behavioral health hospitals, two hospice agencies and two homecare agencies, have attributed to an increase in salaries, wages, and benefits of $13,565,000 for the year ended December 31, 2023 compared to the same period last year.
New operations, which include one skilled nursing facility acquired May 1, 2023, three assisted living facilities that we began operating on July 1, 2023, two behavioral health hospitals, two hospice agencies and two homecare agencies, have attributed to an increase in salaries, wages, and benefits of $13,565,000 for the year ended December 31, 2023 compared to the prior year.
In 2023, we contributed land to a newly-formed limited liability company resulting in an equity interest in the new entity. The fair value of the land contributed to the entity was $8,000,000 and the related cost basis in the land was $1,770,000, which resulted in a gain of $6,230,000.
In December 2023, we contributed land to a newly-formed limited liability company resulting in an equity interest in the new joint venture. The fair value of the land contributed to the entity was $8,000,000 and the related cost basis in the land was $1,770,000, which resulted in a gain of $6,230,000.
In September 2022, the Company transferred the operations of seven skilled nursing facilities located in Massachusetts and New Hampshire, which resulted in salaries, wages, and benefits decreasing $31,920,000 for the year ended December 31, 2023 compared to the same period last year.
In September 2022, the Company transferred the operations of seven skilled nursing facilities located in Massachusetts and New Hampshire, which resulted in salaries, wages, and benefits decreasing $31,920,000 for the year ended December 31, 2023 compared to the prior year.
Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income was $54,934,000 for the year ended December 31, 2023 compared to $37,323,000 for the same period a year ago.
Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income was $54,934,000 for the year ended December 31, 2023 compared to $37,323,000 in the prior year.
Percentage of Net Operating Revenues Year Ended December 31, 2023 2022 2021 Revenues: Net patient revenues 95.3 % 94.8 % 89.9 % Other revenues 4.7 4.2 4.2 Government stimulus income – 1.0 5.9 Net operating revenues and grant income 100.0 100.0 100.0 Costs and Expenses: Salaries, wages and benefits 62.4 63.2 62.0 Other operating 25.2 26.6 24.8 Facility rent 3.6 3.8 3.8 Depreciation and amortization 3.7 3.7 3.8 Interest 0.1 0.1 0.1 Impairment (recovery) of assets – (0.3 ) 0.8 Total costs and expenses 95.0 97.1 95.3 Income from operations 5.0 2.9 4.7 Non–operating income 1.5 1.0 1.7 Gain on acquisition of equity method investment – – 8.8 Unrealized gains (losses) on marketable equity securities 1.3 (1.4 ) (1.3 ) Income before income taxes 7.8 2.5 13.9 Income tax provision (2.1 ) (0.7 ) (1.0 ) Net income 5.7 1.8 12.9 Net loss attributable to noncontrolling interest 0.2 0.3 0.0 Net income attributable to common stockholders of NHC 5.9 % 2.1 % 12.9 % 33 Table of Contents The following table sets forth the increase or (decrease) in certain items from the consolidated statements of operations as compared to the prior period (dollars in thousands) .
Percentage of Net Operating Revenues Year Ended December 31, 2024 2023 2022 Revenues: Net patient revenues 95.8 % 95.3 % 94.8 % Other revenues 3.5 4.7 4.2 Government grant income 0.7 – 1.0 Net operating revenues and grant income 100.0 100.0 100.0 Costs and Expenses: Salaries, wages and benefits 62.0 62.4 63.2 Other operating 24.6 25.2 26.6 Facility rent 3.3 3.6 3.8 Depreciation and amortization 3.2 3.7 3.7 Interest 0.3 0.1 0.1 Impairment (recovery) of assets – – (0.3 ) Total costs and expenses 93.4 95.0 97.1 Income from operations 6.6 5.0 2.9 Non–operating income 1.4 1.5 1.0 Unrealized gains (losses) on marketable equity securities 2.4 1.3 (1.4 ) Income before income taxes 10.4 7.8 2.5 Income tax provision (2.6 ) (2.1 ) (0.7 ) Net income 7.8 5.7 1.8 Net income (loss) attributable to noncontrolling interest 0.0 0.2 0.3 Net income attributable to common stockholders of NHC 7.8 % 5.9 % 2.1 % 34 Table of Contents The following table sets forth the increase or (decrease) in certain items from the consolidated statements of operations as compared to the prior period (dollars in thousands) .
The ten new operations listed above attributed to an increase in other operating expenses of $9,082,000 for the year ended December 31, 2023 compared to the same period last year.
The ten new operations listed above attributed to an increase in other operating expenses of $9,082,000 for the year ended December 31, 2023 compared to the prior year.
The tables below summarize NHC's overall performance in these Five-Star ratings versus the skilled nursing industry as of December 31, 2023: NHC Ratings Industry Ratings Total number of skilled nursing facilities, end of period 68 Number of 4 and 5-star rated skilled nursing facilities 40 Percentage of 4 and 5-star rated skilled nursing facilities 59% 36% Average rating for all skilled nursing facilities, end of period 3.6 2.9 Development and Growth We are undertaking to expand our post–acute and senior health care operations while protecting our existing operations and markets.
The tables below summarize NHC's overall performance in these Five-Star ratings versus the skilled nursing industry as of December 31, 2024: NHC Ratings Industry Ratings Total number of skilled nursing facilities, end of period 80 Number of 4 and 5-star rated skilled nursing facilities 46 Percentage of 4 and 5-star rated skilled nursing facilities 57% 35% Average rating for all skilled nursing facilities, end of period 3.6 2.8 Development and Growth We are undertaking to expand our post–acute and senior health care operations while protecting our existing operations and markets.
For the year ended December 31, 2023 our agency nurse staffing expenses decreased $30,682,000, or approximately 44.5%, compared to the same period a year ago.
For the year ended December 31, 2023 our agency nurse staffing expenses decreased $30,682,000, or approximately 44.5%, compared to the prior year.
Income taxes The income tax provision for 2022 is $7,254,000 (an effective income tax rate of 26.6%). 36 Table of Contents Liquidity, Capital Resources and Financial Condition Sources and Uses of Funds Our primary sources of cash include revenues from the operations of our healthcare operations, management and accounting services, rental income, and investment income.
Income taxes The income tax provision for 2023 is $23,450,000 (an effective income tax rate of 26.4%). 38 Table of Contents Liquidity, Capital Resources and Financial Condition Sources and Uses of Funds Our primary sources of cash include revenues from the operations of our healthcare operations, management and accounting services, rental income, and investment income.
We recorded unrealized losses in the amount of $15,806,000 for the decrease in fair value of our marketable equity securities portfolio for the year ended December 31, 2022. The marketable equity securities portfolio consists mainly of publicly-traded healthcare REIT’s and other blue-chip public companies held within our insurance companies.
We recorded unrealized gains in the amount of $14,944,000 for the increase in fair value of our marketable equity securities portfolio for the year ended December 31, 2023. The marketable equity securities portfolio consists mainly of publicly-traded healthcare REIT’s and other blue-chip public companies held within our insurance companies.
The composite skilled nursing facility per diem increased 6.7% in 2023 compared to 2022. Medicare and managed care per diem rates increased 3.3% and 5.9%, respectively, in 2023 compared to 2022. Medicaid and private pay per diem rates increased 9.4% and 5.5%, respectively, in 2023 compared to 2022.
Medicare and managed care per diem rates increased 3.3% and 5.9%, respectively, in 2023 compared to 2022. Medicaid and private pay per diem rates increased 9.4% and 5.5%, respectively, in 2023 compared to 2022.
Our ability to obtain long-term debt to meet our long–term contractual obligations and to finance our operating requirements, growth and development plans will depend upon our future performance, which will be affected by business, economic, financial and other factors, including potential changes in state and federal government payment rates for health care, customer demand, success of our marketing efforts, pressures from competitors, and the state of the economy, including the state of financial and credit markets, as well as many unforeseen factors. 38 Table of Contents Contingencies See Note 17 to the consolidated financial statements for additional information on pending litigation and other contingencies.
Our future performance will be affected by business, economic, financial and other factors, including potential changes in state and federal government payment rates for health care, customer demand, success of our marketing efforts, pressures from competitors, and the state of the economy, including the state of financial and credit markets, as well as many unforeseen factors. 40 Table of Contents Contingencies See Note 17 to the consolidated financial statements for additional information on pending litigation and other contingencies.
Long – term liquidity We expect to meet our long–term liquidity requirements primarily from our cash flows from operating activities, our current cash on hand of $107,076,000, our unrestricted marketable equity and debt securities of $116,544,000, and our borrowing capacity on the $50 million credit facility.
Long – term liquidity We expect to meet our long–term liquidity requirements primarily from our cash flows from operating activities, our current cash on hand of $76,121,000, our unrestricted marketable equity securities of $140,064,000, and our borrowing capacity on the $50 million available line of credit.
Other income Non–operating income increased by $5,519,000, or 49.5% to $16,660,000 compared to the prior year, as further detailed in Note 5 to our consolidated financial statements. We recorded unrealized gains in the amount of $14,944,000 for the increase in fair value of our marketable equity securities portfolio for the year ended December 31, 2023.
Other income Non–operating income increased by $3,030,000, or 18.2% to $19,690,000 compared to the prior year, as further detailed in Note 5 to our consolidated financial statements. We recorded unrealized gains in the amount of $30,958,000 for the increase in fair value of our marketable equity securities portfolio for the year ended December 31, 2024.
The following is a summary of our sources and uses of cash flows (dollars in thousands) : Year Ended One Year Change Year Ended One Year Change 12/31/23 12/31/22 $ % 12/31/22 12/31/21 $ % Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period $ 74,865 $ 119,743 $ (44,878 ) (37.5 ) $ 119,743 $ 158,502 $ (38,759 ) (24.5 ) Cash provided by operating activities 111,216 8,742 102,474 1,172.2 8,742 62,394 (53,652 ) (86.0 ) Cash used in investing activities (17,568 ) (5,978 ) (11,590 ) (193.9 ) (5,978 ) (65,889 ) 59,911 90.9 Cash used in financing activities (42,545 ) (47,642 ) 5,097 10.7 (47,642 ) (35,264 ) (12,378 ) (35.1 ) Cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period $ 125,968 $ 74,865 $ 51,103 68.3 $ 74,865 $ 119,743 $ (44,878 ) (37.5 ) 37 Table of Contents Operating Activities Net cash provided by operating activities for the year ended December 31, 2023 was $111,216,000 as compared to $8,742,000 and $62,394,000 for the years ended December 31, 2022 and 2021, respectively.
The following is a summary of our sources and uses of cash flows (dollars in thousands) : Year Ended One Year Change Year Ended One Year Change 12/31/24 12/31/23 $ % 12/31/23 12/31/22 $ % Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period $ 125,968 $ 74,865 $ 51,103 68.3 % $ 74,865 $ 119,743 $ (44,878 ) (37.5 )% Cash provided by operating activities 107,303 111,216 (3,913 ) (3.5 ) 111,216 8,742 102,474 1,172.2 Cash used in investing activities (236,693 ) (17,568 ) (219,125 ) (1,247.3 ) (17,568 ) (5,978 ) (11,590 ) (193.9 ) Cash provided by / (used in) financing activities 100,344 (42,545 ) 142,889 335.9 (42,545 ) (47,642 ) 5,097 10.7 Cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period $ 96,922 $ 125,968 $ (29,046 ) (23.1 )% $ 125,968 $ 74,865 $ 51,103 68.3 % 39 Table of Contents Operating Activities Net cash provided by operating activities for the year ended December 31, 2024 was $107,303,000 as compared to $111,216,000 and $8,742,000 for the years ended December 31, 2023 and 2022, respectively.
The transfer of the operations of the seven skilled nursing facilities located in Massachusetts and New Hampshire, as noted above, resulted in other operating expenses decreasing $15,025,000 for the year ended December 31, 2023 compared to the prior year.
The transfer of the operations of the seven skilled nursing facilities located in Massachusetts and New Hampshire, as noted above, resulted in other operating expenses decreasing $15,025,000 for the year ended December 31, 2023 compared to the prior year. Facility rent expense increased $548,000, or 1.3%, to $41,525,000. Depreciation and amortization increased 3.8% to $42,034,000.
For the year ended December 31, 2021, included are facilities that began operations from 2019 to 2021, which is two behavioral health hospitals and one memory care facility. 32 Table of Contents The table below provides reconciliations of GAAP to non-GAAP items ( dollars in thousands, except per share data ): Year Ended December 31, 2023 2022 2021 Net income attributable to National HealthCare Corporation $ 66,798 $ 22,445 $ 138,590 Non-GAAP adjustments: Unrealized (gains) losses on marketable equity securities (14,944 ) 15,806 13,863 Gain on sale of property and equipment (6,230 ) – – Gain on acquisition of equity method investment – – (95,202 ) Stock-based compensation expense 2,782 2,612 2,620 Operating results for newly-opened operations not at full capacity 2,359 5,416 922 Impairment (recovery) of assets – (3,728 ) 8,225 Income tax expense (benefit) on non-GAAP adjustments 4,169 (5,228 ) (6,373 ) Non-GAAP Net Income $ 54,934 $ 37,323 $ 62,645 GAAP diluted earnings per share $ 4.34 $ 1.45 $ 8.99 Non-GAAP adjustments: Unrealized (gains) losses on marketable equity securities (0.72 ) 0.76 0.67 Gain on sale of property and equipment (0.30 ) – – Gain on acquisition of equity method investment – – (6.16 ) Stock-based compensation expense 0.13 0.13 0.13 Operating results for newly-opened operations not at full capacity 0.10 0.26 0.04 Impairment (recovery) of assets – (0.18 ) 0.39 Non-GAAP diluted earnings per share $ 3.55 $ 2.42 $ 4.06 Results of Operations The following table and discussion set forth items from the consolidated statements of operations as a percentage of net operating revenues and grant income for the years ended December 31, 2023, 2022 and 2021.
For the year ended December 31, 2022, included are two behavioral health hospitals, one hospice agency, and one homecare agency. 33 Table of Contents The table below provides reconciliations of GAAP to non-GAAP items ( dollars in thousands, except per share data ): Year Ended December 31, 2024 2023 2022 Net income attributable to National HealthCare Corporation $ 101,927 $ 66,798 $ 22,445 Non-GAAP adjustments: Unrealized (gains) losses on marketable equity securities (30,958 ) (14,944 ) 15,806 Stock-based compensation expense 4,160 2,782 2,612 Operating results for newly-opened operations not at full capacity 130 2,359 5,416 Acquisition-related expenses 3,266 – – Employee retention credit (9,445 ) – – Gain on sale of unconsolidated company (1,024 ) – – Gain on sale of property and equipment – (6,230 ) – Impairment (recovery) of assets – – (3,728 ) Income tax expense (benefit) on non-GAAP adjustments 8,806 4,169 (5,228 ) Non-GAAP Net Income $ 76,862 $ 54,934 $ 37,323 GAAP diluted earnings per share $ 6.53 $ 4.34 $ 1.45 Non-GAAP adjustments: Unrealized (gains) losses on marketable equity securities (1.47 ) (0.72 ) 0.76 Stock-based compensation expense 0.20 0.13 0.13 Operating results for newly-opened operations not at full capacity 0.01 0.10 0.26 Acquisition-related expenses 0.16 – – Employee retention credit (0.45 ) – – Gain on sale of unconsolidated company (0.05 ) – – Gain on sale of property and equipment – (0.30 ) – Impairment (recovery) of assets – – (0.18 ) Non-GAAP diluted earnings per share $ 4.93 $ 3.55 $ 2.42 Results of Operations The following table and discussion set forth items from the consolidated statements of operations as a percentage of net operating revenues and grant income for the years ended December 31, 2024, 2023 and 2022.
The overall average census in owned and leased skilled nursing facilities for 2022 was 83.8% compared to 80.6% in 2021. The composite skilled nursing facility per diem increased 2.3% in 2022 compared to 2021. Medicare and managed care per diem rates increased 2.3% and 6.0%, respectively, in 2022 compared to 2021.
The overall average census in owned and leased skilled nursing facilities for 2024 was 88.6% compared to 87.9% in 2023. The composite skilled nursing facility per diem increased 6.8% in 2024 compared to 2023. Medicare and managed care per diem rates increased 5.0% and 0.7%, respectively, in 2024 compared to 2023.
In addition, we provide management services, accounting and financial services, and insurance services to third party operators of healthcare properties. We also own the real estate of 10 healthcare properties and lease these properties to third party operators.
In addition, we provide management services, accounting and financial services, and insurance services to third party operators of healthcare properties.
Type of Operation Description Size Location Placed in Service Hospice Acquisition 28 agencies Various June 2021 Homecare New Agency 1 agency Anderson, SC January 2022 Hospice New Agency 1 agency Tullahoma, TN March 2022 Behavioral Health Hospital New Facility 64 beds Knoxville, TN April 2022 Behavioral Health Hospital New Facility 16 beds St.
The following table lists our recent construction and purchase activities. Type of Operation Description Size Location Placed in Service Homecare New Agency 1 agency Anderson, SC January 2022 Hospice New Agency 1 agency Tullahoma, TN March 2022 Behavioral Health Hospital New Facility 64 beds Knoxville, TN April 2022 Behavioral Health Hospital New Facility 16 beds St.
Segment Reporting The Company has two reportable operating segments: (1) inpatient services, which includes the operation of skilled nursing facilities, assisted and independent living facilities, and behavioral health hospitals; and (2) homecare and hospice services.
Our experience is that achieving goals in these patient care areas improves both patient and employee satisfaction. Segment Reporting The Company has two reportable operating segments: (1) inpatient services, which includes the operation of skilled nursing facilities, assisted and independent living facilities, and behavioral health hospitals; and (2) homecare and hospice services.
At December 31, 2023, we operate or manage 68 skilled nursing facilities with 8,732 1icensed beds, 26 assisted living facilities with 1,501 units, five independent living facilities, three behavioral health hospitals, 35 homecare agencies, and 30 hospice agencies located in 8 states.
At December 31, 2024, we operate or manage 80 skilled nursing facilities with 10,341 1icensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies located in 9 states.
Included in the adjustments for non-cash items are depreciation expense, equity in earnings of unconsolidated investments, unrealized losses on our marketable equity securities, recovery of assets, deferred taxes, and stock compensation.
In 2023, there was cash provided by working capital in the amount of $17,396,000. Included in the adjustments for non-cash items are depreciation expense, equity in earnings of unconsolidated investments, unrealized losses on our marketable equity securities, gain on the sale of an unconsolidated company, deferred taxes, and stock compensation.
The operating results for the start-up operations not at full capacity include the following: for the year ended December 31, 2023, included are operations that began from 2021 to 2023, which is two behavioral health hospitals, two homecare agencies, and two hospice agencies.
The operating results for newly opened facilities or agencies not at full capacity include newly constructed healthcare facilities or agencies that are still considered in the start-up phase, which include two hospice agencies for the year ended December 31, 2024. For the year ended December 31, 2023, included are two behavioral health hospitals, two homecare agencies, and two hospice agencies.
Additionally, NHC is in various stages of partnerships with hospital systems, payors, and other post–acute alliances to better position ourselves so we are an active participant in the delivery of post-acute healthcare services. Quality of Patient Care CMS introduced the Five-Star Quality Rating System to help consumers, their families and caregivers compare skilled nursing facilities more easily.
Additionally, NHC is in various stages of partnerships with hospital systems, payors, and other post–acute alliances to better position ourselves so we are an active participant in the delivery of post-acute healthcare services.
We have set aside restricted cash and restricted marketable securities to fund our professional liability and workers’ compensation reserves. As to exposure for professional liability claims, we have developed performance measures to bring focus to the patient care issues most likely to produce professional liability exposure, including in–house acquired pressure ulcers, significant weight loss and numbers of falls.
As to exposure for professional liability claims, we have developed performance measures to bring focus to the patient care issues most likely to produce professional liability exposure, including in–house acquired pressure ulcers, significant weight loss and numbers of falls. These programs for certification, which we regularly modify and improve, have produced measurable improvements in reducing these incidents.
Specifically, the Company believes the presentation of non-GAAP financial information should exclude the following items: the unrealized gains or losses on our marketable equity securities, operating results for start-up healthcare operations not at full capacity, any gains on the acquisition of equity method investments, gains on the sale of property and equipment, stock-based compensation expense, and impairments or recoveries of long-lived assets and notes receivable.
Specifically, the Company believes the presentation of non-GAAP financial information that excludes the unrealized gains or losses on our marketable equity securities, stock-based compensation expense, operating results for start-up healthcare operations not at full capacity, acquisition related expenses, the recognition of the employee retention credit, gains on sales of unconsolidated companies, gains on the sale of property and equipment, and impairments or recoveries of long-lived assets is helpful in allowing investors to assess the Company’s operations more accurately.
Period to Period Increase (Decrease) 2023 vs. 2022 2022 vs. 2021 Amount Percent Amount Percent Revenues: Net patient revenues $ 58,529 5.7 % $ 63,543 6.6 % Other revenues 8,734 19.3 (204 ) (0.4 ) Government stimulus income (11,457 ) (100.0 ) (51,903 ) (81.9 ) Net operating revenues and grant income 55,806 5.1 11,436 1.1 Costs and Expenses: Salaries, wages and benefits 26,175 3.8 20,106 3.0 Other operating (1,189 ) (0.4 ) 22,618 8.5 Facility rent 548 1.3 159 0.4 Depreciation and amortization 1,545 3.8 (183 ) (0.4 ) Interest (239 ) (42.5 ) (282 ) (33.4 ) Impairment (recovery) of assets 3,728 100.0 (11,953 ) (145.3 ) Total costs and expenses 30,568 2.9 30,465 3.0 Income from operations 25,238 79.1 (19,029 ) (37.4 ) Non–operating income 5,519 49.5 (6,633 ) (37.3 ) Gain on acquisition of equity method investment – – (95,202 ) (100.0 ) Unrealized gains (losses) on marketable equity securities 30,750 194.5 (1,943 ) (14.0 ) Income before income taxes 61,507 225.9 (122,807 ) (81.9 ) Income tax provision (16,196 ) (223.3 ) 3,697 33.8 Net income 45,311 226.8 (119,110 ) (85.6 ) Net (income) loss attributable to noncontrolling interest (958 ) (38.8 ) 2,965 596.6 Net income attributable to common stockholders of NHC $ 44,353 197.6 % $ (116,145 ) (83.8 )% 2023 Compared to 2022 Results for the year ended December 31, 2023 compared to 2022 include a 5.1% increase in net operating revenues and grant income.
Period to Period Increase (Decrease) 2024 vs. 2023 2023 vs. 2022 Amount Percent Amount Percent Revenues: Net patient revenues $ 164,145 15.1 % $ 58,529 5.7 % Other revenues (7,752 ) (14.4 ) 8,734 19.3 Government grant income 9,445 100.0 (11,457 ) (100.0 ) Net operating revenues and grant income 165,838 14.5 55,806 5.1 Costs and Expenses: Salaries, wages and benefits 98,586 13.8 26,175 3.8 Other operating 33,207 11.5 (1,189 ) (0.4 ) Facility rent 1,657 4.0 548 1.3 Depreciation and amortization (49 ) (0.1 ) 1,545 3.8 Interest 3,811 1,176.2 (239 ) (42.5 ) Impairment (recovery) of assets – – 3,728 100.0 Total costs and expenses 137,212 12.7 30,568 2.9 Income from operations 28,626 50.1 25,238 79.1 Non–operating income 3,030 18.2 5,519 49.5 Unrealized gains (losses) on marketable equity securities 16,014 107.2 30,750 194.5 Income before income taxes 47,670 53.7 61,507 225.9 Income tax provision (10,872 ) (46.4 ) (16,196 ) (223.3 ) Net income 36,798 56.4 45,311 226.8 Net (income) loss attributable to noncontrolling interest (1,669 ) (110.5 ) (958 ) (38.8 ) Net income attributable to common stockholders of NHC $ 35,129 52.6 % $ 44,353 197.6 % 2024 Compared to 2023 Net operating revenues and grant income for the year ended December 31, 2024 totaled $1,307,382,000 compared to $1,141,544,000 for the year ended December 31, 2023, an increase of 14.5%.
Other operating expenses increased $22,618,000, or 8.5%, to $289,372,000 for the year ended December 31, 2022 compared to $266,754,000 for the prior year. Other operating expenses as a percentage of net operating revenues and grant income was 26.7% and 24.8% for the years ended December 31, 2022 and 2021, respectively.
Other operating expenses increased $33,207,000, or 11.5%, to $321,390,000 for the year ended December 31, 2024 compared to $288,183,000 for the prior year. Other operating expenses as a percentage of net operating revenues and grant income was 24.6% and 25.2% for the years ended December 31, 2024 and 2023, respectively.
In September 2022, the Company transferred the operations of seven skilled nursing facilities located in Massachusetts and New Hampshire, which resulted in net patient revenues decreasing $48,820,000 for the year ended December 31, 2023 compared to the same period last year. 34 Table of Contents Other revenues in 2023 were $53,930,000, an increase of $8,734,000, or 19.3%, as further detailed in Note 4 to our consolidated financial statements.
In September 2022, the Company transferred the operations of seven skilled nursing facilities located in Massachusetts and New Hampshire, which resulted in net patient revenues decreasing $48,820,000 for the year ended December 31, 2023 compared to the prior year.
For the year ended December 31, 2023, GAAP net income attributable to NHC was $66,798,000 compared to net income of $22,445,000 for the same period in 2022.
The net operating revenues increase was primarily driven by the continued occupancy increase in our skilled nursing facilities and increases in skilled nursing per diems from some of our governmental payors. For the year ended December 31, 2023, GAAP net income attributable to NHC was $66,798,000 compared to net income of $22,445,000 for the same period in 2022.
Included in net patient revenues for the years ended December 31, 2023 and 2022, respectively, is $20,214,000 and $19,442,000 of supplemental Medicaid payments that were received to help mitigate the inflationary labor and medical supplies costs caused by the pandemic. The overall average census in owned and leased skilled nursing facilities for 2023 was 87.9% compared to 83.8% in 2022.
Included in net patient revenues for the years ended December 31, 2023 and 2022, respectively, is $20,214,000 and $19,442,000 of supplemental Medicaid payments that were received to help mitigate the inflationary labor and medical supplies costs caused by the pandemic. 37 Table of Contents Other revenues in 2023 were $53,930,000, an increase of $8,734,000, or 19.3%, as further detailed in Note 4 to our consolidated financial statements.
Income taxes The income tax provision for 2023 is $23,450,000 (an effective income tax rate of 26.4%). 2022 Compared to 2021 Results for the year ended December 31, 2022 compared to 2021 include a 1.1% increase in net operating revenues and grant income.
Income taxes The income tax provision for 2024 is $34,322,000 (an effective income tax rate of 25.2%). 36 Table of Contents 2023 Compared to 2022 Net operating revenues and grant income for the year ended December 31, 2023 totaled $1,141,544,000 compared to $1,085,738,000 for the year ended December 31, 2022, an increase of 5.1%.
Excluding the gain on the Caris acquisition, as well as the unrealized losses in our marketable equity securities portfolio and the other non-GAAP adjustments, non-GAAP net income for the year ended December 31, 2022 was $37,323,000 compared to $62,645,000 for the year ended December 31, 2021.
Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income was $76,862,000 for the year ended December 31, 2024 compared to $54,934,000 for the same period a year ago.
Cash provided by operating activities consisted of net income of $65,288,000 and adjustments for non–cash items of $33,625,000. There was cash provided by working capital in the amount of $17,396,000 for the year ended December 31, 2023 compared to cash used for working capital needs in the amount of $73,697,000 in 2022.
Cash provided by operating activities consisted of net income of $102,086,000 and adjustments for non–cash items of $32,027,000. There was cash used for working capital needs in the amount of $25,717,000 for the year ended December 31, 2024, which was primarily driven by the White Oak acquisition.
In addition to cash flows from operations, we have current cash on hand of $107,076,000 and unrestricted marketable equity and debt securities of $116,544,000. We also have unencumbered real estate, as well the borrowing capacity on our $50 million credit facility, that can be used to meet our contractual obligations and growth and development plans in the next twelve months.
In addition to cash flows from operations, we have current cash on hand of $76,121,000 and unrestricted marketable equity securities of $140,064,000. We also have unencumbered real estate and the borrowing capacity on our $50 million available line of credit.
We incurred increased expenses from our professional liability actuarial report in the fourth quarter of 2022 compared to the prior year of $3,284,000. We also continue to face inflationary pressures in certain categories within other operating expenses as well, such as food/dietary supplies and drugs/pharmaceutical supplies. Facility rent expense increased $159,000, or 0.4%, to $40,977,000.
The exiting of these operations resulted in other operating expenses decreasing $7,101,000 for the year ended December 31, 2024 compared to the prior year. We continue to face inflationary pressures in certain categories within other operating expenses as well, such as food/dietary supplies and drugs/pharmaceutical supplies. Facility rent expense increased $1,657,000, or 4.0%, to $43,182,000.
Net operating revenues and grant income Net patient revenues totaled $1,087,614,000 an increase of $58,529,000, or 5.7%, compared to the prior year.
Net operating revenues and grant income Net patient revenues totaled $1,087,614,000 in 2023, an increase of $58,529,000, or 5.7%, compared to the prior year. The overall average census in owned and leased skilled nursing facilities for 2023 was 87.9% compared to 83.8% in 2022. The composite skilled nursing facility per diem increased 6.7% in 2023 compared to 2022.
Salaries, wages, and benefits increased $20,106,000, or 3.0%, to $686,169,000 from $666,063,000. Salaries, wages, and benefits as a percentage of net operating revenues and grant income was 63.2% compared to 62.0% for the years ended December 31, 2022 and 2021, respectively.
Salaries, wages, and benefits as a percentage of net operating revenues and grant income was 62.0% compared to 62.4% for the years ended December 31, 2024 and 2023, respectively. The White Oak operations attributed to an increase of $63,223,000 in salaries, wages, and benefits for the year ended December 31, 2024 compared to the prior year.
We also have substantial value in our unencumbered real estate assets which could potentially be used as collateral in future borrowing opportunities. At December 31, 2023, we do not have any long-term debt.
We also have substantial value in our unencumbered real estate assets, which could potentially be used as collateral in future borrowing opportunities. Our ability to obtain long-term debt to meet our long–term contractual obligations and to finance our operating requirements, growth and development plans will depend upon our future performance.
We repurchased common shares outstanding in the amount of $2,482,000, $9,903,000, and $836,000 for the years ended December 31, 2023, 2022, and 2021, respectively. Short – term liquidity We expect to meet our short–term liquidity requirements primarily from our cash flows from operating activities.
Principal payments made under finance lease obligations was $860,000, $4,985,000, and $4,695,000 for the years ended December 31, 2024, 2023, and 2022, respectively. The finance lease obligations terminated during the first quarter of 2024. Short – term liquidity We expect to meet our short–term liquidity requirements primarily from our cash flows from operating activities.
Louis, MO June 2022 Hospice New Agency 1 agency Cedar Bluff, VA March 2023 Skilled Nursing Acquisition 66 beds Nashville, TN May 2023 Homecare New Agency 1 agency Tallahassee, FL May 2023 Assisted Living Facility New Operations 135 units Vero Beach, FL July 2023 Assisted Living Facility New Operations 95 units Merritt Island, FL July 2023 Assisted Living Facility New Operations 100 units Stuart, FL July 2023 Accrued Risk Reserves Our accrued professional liability and workers’ compensation reserves totaled $103,259,000 and $102,469,000 at December 31, 2023 and 2022, respectively, and are a primary area of management focus.
Louis, MO June 2022 Hospice New Agency 1 agency Cedar Bluff, VA March 2023 Skilled Nursing Acquisition 66 beds Nashville, TN May 2023 Homecare New Agency 1 agency Tallahassee, FL May 2023 Assisted Living Facility New Operations 135 units Vero Beach, FL July 2023 Assisted Living Facility New Operations 95 units Merritt Island, FL July 2023 Assisted Living Facility New Operations 100 units Stuart, FL July 2023 Hospice New Agency 1 agency Morristown, TN April 2024 Hospice New Agency 1 agency Lawrenceburg, TN July 2024 Hospice New Agency 1 agency Wytheville, VA August 2024 Hospice New Agency 1 agency Clinton, TN October 2024 30 Table of Contents On August 1, 2024, the Company purchased the White Oak portfolio, including its long-term care pharmacy.
Investing Activities Net cash used in investing activities totaled $17,568,000 for the year ended December 31, 2023, as compared to $5,978,000 and $65,889,000 for the years ended December 31, 2022 and 2021, respectively. Cash used for property and equipment additions was $27,901,000, $30,200,000, and $39,399,000 for the years ended December 31, 2023, 2022 and 2021, respectively.
Investing Activities Net cash used in investing activities totaled $236,693,000 for the year ended December 31, 2024, as compared to $17,568,000 and $5,978,000 for the years ended December 31, 2023 and 2022, respectively. On August, 1, 2024, the acquisition of White Oak resulted in cash used of $215,896,000, as described in Note 2 to our consolidated financial statements.
Financing Activities Net cash used in financing activities totaled $42,545,000, $47,642,000, and $35,264,000 for the years ended December 31, 2023, 2022, and 2021, respectively. Principal payments made under finance lease obligations was $4,985,000, $4,695,000, and $4,423,000 for the years ended December 31, 2023, 2022, and 2021, respectively.
Financing Activities Net cash provided by financing activities totaled $100,344,000 for the year ended December 31, 2024. Net cash used in financing activities totaled $42,545,000 and $47,642,000 for the years ended December 31, 2023 and 2022, respectively. The funding for the White Oak acquisition was provided by the Company’s cash on hand and borrowings of $150,000,000.
Dividends paid to common stockholders was $35,560,000, $34,604,000, and $32,030,000 for the years ended December 31, 2023, 2022 and 2021, respectively. Proceeds from the issuance of common stock totaled $313,000, $2,114,000, and $3,441,000 for 2023, 2022 and 2021, respectively.
Proceeds from the issuance of common stock totaled $14,268,000, $313,000, and $2,114,000 for 2024, 2023 and 2022, respectively. We repurchased common shares outstanding in the amount of $13,502,000, $2,482,000, and $9,903,000 for the years ended December 31, 2024, 2023, and 2022, respectively.
Depreciation and amortization decreased 0.4% to $40,489,000. Interest expense decreased $282,000 to $563,000 in 2022 from $845,000 in 2021. At December 31, 2022, we have no outstanding long-term debt. During 2022, we had a note receivable recovery of $3,728,000.
Depreciation and amortization decreased 0.1% to $41,985,000. Interest expense increased $3,811,000 to $4,135,000 in 2024 from $324,000 in 2023. At December 31, 2024, we have outstanding long-term debt of $137,000,000 due to the White Oak acquisition. In 2023, we didn't have any outstanding long-term debt.
Proceeds from the sale of marketable securities, net of purchases, resulted in cash proceeds of $17,895,000 and $16,168,000 in 2023 and 2022, respectively. For the year ended December 31, 2022, the Company collected notes receivable of $3,879,000 and received proceeds from the sale of property and equipment of $4,175,000.
In January 2024, the Company sold its 50% joint venture ownership interest in a homecare agency resulting in proceeds from the sale of $2,100,000. Proceeds from the sale of marketable securities, net of purchases, resulted in cash proceeds of $16,913,000, $17,895,000, and $16,168,000 in 2024, 2023, and 2022, respectively.
Medicaid and private pay per diem rates increased 3.0% and 4.7%, respectively, in 2022 compared to 2021. In June 2021, the Company acquired the remaining ownership interest in Caris, which resulted in net patient revenues increasing $31,566,000 for the year ended December 31, 2022 compared to the prior year.
Medicaid and private pay per diem rates increased 8.6% and 12.3%, respectively, in 2024 compared to 2023. White Oak, with five months of operations since the acquisition date, attributed to an increase of $96,052,000 in net patient revenues for the year ended December 31, 2024 compared to 2023.
Other income Non–operating income decreased by $6,633,000, or 37.3% to $11,141,000 compared to the prior year, as further detailed in Note 5 to our consolidated financial statements. The decrease in our non-operating income is due to the June 2021 acquisition of Caris.
Interest expense decreased $239,000 to $324,000 in 2023 from $563,000 in 2022. At December 31, 2023, we have no outstanding long-term debt. Other income Non–operating income increased by $5,519,000, or 49.5% to $16,660,000 compared to the prior year, as further detailed in Note 5 to our consolidated financial statements.
For the year ended December 31, 2022, GAAP net income attributable to NHC was $22,445,000 compared to net income of $138,590,000 for the same period in 2021. The large decrease in our reported GAAP net income for 2022 was primarily due to the $95.2 million gain recorded in 2021 from the acquisition of Caris.
The net operating revenues increase was primarily driven by the August 1, 2024 acquisition of White Oak Manor ("White Oak"). For the year ended December 31, 2024, GAAP net income attributable to NHC was $101,927,000 compared to net income of $66,798,000 for the same period in 2023.
For the year ended December 31, 2022, our agency nurse staffing expenses were $68,875,000 compared to $36,391,000 for the 2021 year. In September 2022, the Company transferred the operations of seven skilled nursing facilities located in Massachusetts and New Hampshire resulting in salaries, wages, and benefits decreasing $18,053,000 for the year ended December 31, 2022 compared to the prior year.
On March 1, 2024, the Company exited the lease and transferred the operations of two skilled nursing facilities (included assisted living units) and one memory care facility located in Missouri. The exiting of these operations resulted in salaries, wages, and benefits decreasing $20,169,000 for the year ended December 31, 2024 compared to the prior year.
The Company’s assessment of whether the terms and conditions for amounts received have been met for income recognition and the Company’s related income calculation considered all frequently asked questions and other interpretive guidance issued to date by HHS. 29 Table of Contents Executive Summary Earnings To monitor our earnings, we have developed budgets and management reports to monitor labor, census, and the composition of revenues.
We also own the real estate of 10 healthcare properties and lease these properties to third party operators. 29 Table of Contents Executive Summary Earnings To monitor our earnings, we have developed budgets and management reports to monitor labor, census, and the composition of revenues.
In September 2022, the Company transferred the operations of seven skilled nursing facilities located in Massachusetts and New Hampshire resulting in net patient revenues decreasing $18,732,000 for the year ended December 31, 2022 compared to the prior year. 35 Table of Contents Other revenues in 2022 were $45,196,000, a decrease of $204,000, or 0.4%, as further detailed in Note 4 to our consolidated financial statements.
Also included in net patient revenues for the years ended December 31, 2024 and 2023, respectively, is $12,749,000 and $20,214,000 of supplemental Medicaid payments that were received to help mitigate the healthcare workforce crisis and the inflationary labor market. 35 Table of Contents Other revenues in 2024 were $46,178,000, a decrease of $7,752,000, or 14.4%, as further detailed in Note 4 to our consolidated financial statements.
Our Caris acquisition in June 2021 increased salaries, wages, and benefits $19,040,000 for the year ended December 31, 2022 compared to 2021. We continue to face workforce and labor shortages within all of our operations, which increases wage pressure in regards to retaining and attracting qualified healthcare partners (employees).
We continue to face workforce and labor shortages within all of our operations. The labor and workforce shortages have resulted in us contracting with agency nurse staffing companies. For the year ended December 31, 2024 our agency nurse staffing expenses decreased $19,962,000, or approximately 66.2%, compared to the same period a year ago.